Governing Board and Advisory Council
R4R is governed by a Governing Board, comprised of experts from health, public policy and business. The Board is supported by the Advisory Council, providing advice on emerging issues related to matters of cleaner, healthier, and more resilient growth.
José Manuel Barroso
Chair of Gavi; President of the European Commission (2004-14)
José Manuel Barroso is Chairman of Goldman Sachs International, Chair of Gavi, the Vaccine Alliance, and former President of the European Commission (2004-14). José Manuel joined Goldman Sachs in 2016 after an established career in EU and Portuguese politics. Having first been elected to the Portuguese Parliament in 1985, José Manuel served as state secretary for home affairs, state secretary for foreign affairs and cooperation, and minister for foreign affairs in successive governments. In 1999, he was elected president of the Social Democratic Party and became the leader of the opposition. In 2002, he was elected Prime Minister of Portugal and in 2004 was nominated as President of the European Commission. José Manuel remained in the Presidency for two 5-year terms, where he played an influential role in the passing of the Treaty of Lisbon, responding to the financial crisis and incorporating new members in the European Union, as the EU went from 15 to 28 countries between 2004 and 2014. On behalf of the EU, Jose Manuel received the Nobel Peace Prize in 2012 and gave the acceptance speech together with the President of the European Council. José Manuel’s academic positions have included visiting professor at Georgetown University and visiting professor of International Economic Policy and policy fellow at the Woodrow Wilson School, at Princeton University. He is also a visiting professor at the Catholic University of Portugal and at the Graduate Institute of International and Development Studies in Geneva. José Manuel has been awarded numerous honorary degrees and has received more than 60 decorations, prizes and honors, including Portugal’s Grã-Cruz da Ordem Militar de Cristo and Grande Colar da Ordem do Infante Dom Henrique.
Prime Minister of Australia (2015-18)
Malcolm Turnbull was 29th Prime Minister of Australia from 2015 to 2018. Prior to entering politics, he enjoyed successful careers as a lawyer, investment banker and journalist. Malcolm co-founded the first big Australian Internet company, OzEmail Ltd, listing it on the NASDAQ in 1996 and selling it to WorldCom three years later. He joined Goldman Sachs in 1997, becoming a partner of the firm the following year and headed their Australian business for four years until he retired to pursue a political career. He entered the Australian Parliament in 2004 and during that time served as Minister for the Environment and Water Resources, Minister for Communications and as Prime Minister from 2015-18. During his time as Prime Minister, Malcolm delivered an economic growth agenda that lead to record job creation on the back of cutting personal and company taxes. His government legalized same-sex marriage and reformed the school funding model to ensure a consistent, needs based approach across all school sectors. His government embarked on the largest peace-time expansion and modernization of Australian defense forces and defense industry, including commissioning 54 new naval vessels. Malcolm has a deep interest in energy issues and renewable energy. He recognized the urgent need for large scale storage to make intermittent renewables reliable and started the construction of the Snowy Hydro 2.0 pumped hydro scheme, which will be the largest in the Southern Hemisphere. He also identified the opportunity for similar pumped storage systems in Tasmania. He successfully negotiated a deal with President Trump to maintain a refugee resettlement deal he had agreed to with President Obama. When Trump pulled out of the Trans Pacific Partnership, Malcolm refused to allow that 12-nation free trade deal to fall by the wayside, rallying the remaining 11 countries to commit to a continuing TPP-11. He radically reformed the way the Australian federal government deals with states and cities, establishing a series of City Deals where the three levels of government agree on common goals and then work together to realize them. As part of the Western Sydney City Deal, he commenced the construction of a new airport for Sydney. At a time of growing nationalist sentiment across the world, he opposed racism and division at every turn, ensuring that Australia remains the most successful multicultural society in the world. Since leaving politics, Malcolm has resumed his business career and regularly speaks at global conferences.
Michelle A. Williams
Dean of the Faculty, Harvard T.H. Chan School of Public Health
Michelle A. Williams is Dean of the Faculty, Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development. Michelle is an internationally renowned epidemiologist, public health scientist, award-winning educator and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and Program Leader of the Population Health and Health Disparities Research. Before joining Harvard, Michelle had a distinguished career at the University of Washington (UW) School of Public Health. While at the UW, she was active in the Center for Perinatal Studies at the Swedish Medical Center in Seattle, becoming co-director from 2000 to 2011. In 1994, Michelle developed, and directed until 2019, the international research training (MIRT) program that allows for the development and operations of undergraduate and graduate student training in global health, biostatistics, and epidemiology in foreign research sites in South America, South East Asia, Africa, and Europe. Michelle has been recognized for her excellence in teaching, as the recipient of the 2015 Harvard Chan School’s Outstanding Mentor Award, the UW’s Brotman Award for excellence in teaching (2007), the American Public Health Association’s Abraham Lilienfeld Award for education in epidemiology (2007), and the White House’s Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring (2012). She is a member of the National Academy of Medicine, the Society for Epidemiologic Research, and the American Epidemiological Society (elected). In 2020, she was awarded the Ellis Island Medal of Honor.
Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine
David Heymann is Professor of Infectious Disease Epidemiology at LSHTM and former Head of the Centre on Global Health Security at Chatham House, London. From 2012 to 2017 he was chairman of Public Health England. David is an elected fellow of the Institute of Medicine of the National Academies (US) and the Academy of Medical Sciences (UK), and has received seven different public health awards. David has held numerous positions at WHO, including Executive Director of the Communicable Diseases Cluster, leading the global response to SARS, and Assistant Director for Health Security. Before joining WHO, David was based in sub-Saharan Africa and India, responding to outbreaks of Ebola, smallpox and supporting research to control infectious diseases.
Distinguished Professor, Genomics Research Center, Academia Sinica; Vice President of Taiwan (2016-20)
Chen Chien-Jen received his Sc.D. in epidemiology and human genetics from the Johns Hopkins University (1983). He then worked as an associate professor (1983–1986) and professor (1986–2006) of National Taiwan University. He was appointed as the director of the Graduate Institute of Public Health (1993–1994), founding director of the Graduate Institute of Epidemiology (1994–1997), and dean of the College of Public Health at National Taiwan University (1999–2002). He became a distinguished research fellow of the Genomics Research Center at Academia Sinica (2006–2015), and was appointed as a vice president of the academy (2011– 2015). He was appointed as the Minister of the Department of Health (2003–2005) and Minister of the National Science Council (2006–2008). He was elected as the 14th Vice President of the Republic of China (Taiwan). He is now an academician and distinguished research fellow of the Genomics Research Center, Academia Sinica. Chien-Jen has dedicated himself to molecular and genomic epidemiological research on chronic arsenic poisoning and virus-induced cancers for over 40 years. His discoveries of the multiple health hazards of arsenic in drinking water has led to global awareness and mitigation of this large environmental calamity, and his research on end-stage liver disease risk prediction in chronic hepatitis B has pioneered the viral load paradigm in its clinical management. He has published over 750 scientific articles and over 75 books/chapters, which have been cited for over 93,000 times with an H-index over 140 (Google Scholar). Chien-Jen was elected as an academician of Academia Sinica (1998), a member of the World Academy of Sciences (2005), an honorary member of the Mongolian Academy of Sciences (2007), and a Foreign Associate (international member) of US National Academy of Sciences (2017). He has received many awards and honors, including the Presidential Science Prize (2005) and the Order of Dr. Sun Yat-sen with Grand Cordon (2020) in Taiwan, the Cutter Lectureship on Preventive Medicine from Harvard University (2008) and the Knowledge for the World Award from Johns Hopkins University (2012) in the USA, the Officier of the Ordre des Palmes Académiques (2009) in France, the Knight of the Equestrian Order of the Holy Sepulchre (2010) and the Pontifical Equestrian Order of St. Gregory the Great (2013) in the Vatican. He received honorary doctoral degrees from China Medical University (2014), National Sun Yet-Sen University (2020), and Kaohsiung Medical University (2020) in Taiwan.
Leif Johansson is Chairman of AstraZeneca. From 1997 to 2011, Leif was CEO of AB Volvo. Prior to that, he served at AB Electrolux, latterly as CEO from 1994 to 1997. He was a Non-Executive Director of BMS from 1998 to September 2011. Leif was Chairman of global telecommunications company, LM Ericsson, from 2011 until March 2018. He holds an MSc in engineering from Chalmers University of Technology, Gothenburg. He has been a member of the Royal Swedish Academy of Engineering Sciences since 1994 (Chairman 2012 to 2017). Leif is also a member of the European Round Table of Industrialists (Chairman 2009 to 2014) and a Member of the Council of Advisors, Boao Forum for Asia.
Syaru Shirley Lin
Chair, Center for Asia-Pacific Resilience and Innovation
Research Professor, Miller Center, University of Virginia
Adjunct Professor, Chinese University of Hong Kong
Syaru Shirley Lin is Research Professor at the Miller Center of Public Affairs at the University of Virginia and a Nonresident Senior Fellow in the Foreign Policy Program of Brookings Institution. She is also an Adjunct Professor at the Chinese University of Hong Kong. Shirley chairs the Center for Asia-Pacific Resilience and Innovation (CAPRI), a new policy think tank conducting interdisciplinary, comparative research on innovative policies that can strengthen resilience and improve governance in the Asia Pacific. CAPRI currently acts as the Asia-Pacific Hub of the Reform for Resilience Commission and the Partnership for Health System Sustainability and Resilience, two global initiatives that are reviewing the response to the COVID pandemic and developing proposals for better responses in the future. Her research and teaching focus on cross-Strait relations, international and comparative political economy, as well as the challenges facing high-income societies in East Asia. She is the author of Taiwan’s China Dilemma: Contested Identities and Multiple Interests in Taiwan’s Cross-Strait Economic Policy (Stanford University Press, 2016) which was also published in Chinese in 2019. Her book highlights the linkage between Taiwan’s national identity and its foreign economic policy and analyzes the implications for Taiwan’s future relationship with China. She is now writing a book on six economies in Asia Pacific caught in the high-income trap, all of which are facing problems such as inequality, demographic decline, financialization, outdated education systems, increasingly polarized societies, inadequate policy and technological innovation, and climate change. Her analysis and commentary frequently appear in English and Chinese media. She was the youngest woman partner as well as one of the first Asian partners of Goldman Sachs, where she led the firm’s investment efforts in Asia, managing private equity and venture capital investments in 12 countries and setting up its Tokyo operation. She spearheaded the firm’s investments in technology start-ups in Asia, making it one of the earliest and most successful investors in China. In that capacity, she led the first round of institutional investments in Alibaba and Semiconductor Manufacturing International Corporation. Prior to her work in private equity and venture capital, she specialized in the privatization of state-owned enterprises in China and Singapore. Shirley has served on the boards of numerous private and public companies and currently serves as a director of TE Connectivity, Goldman Sachs Asia Bank, and Langham Hospitality Investments. She is a director of the Focused Ultrasound Foundation, which supports the development and adoption of new therapeutic medical technologies, and a senior advisor to Taiwan's Talent Circulation Alliance, an initiative to promote Taiwan as a hub for talent for the region and the world. She served on the Hong Kong Committee for Pacific Economic Cooperation from 2016 to 2022, advising the Hong Kong government on matters related to the Pacific Economic Cooperation Council. A native of Taipei, Shirley has been a resident of Hong Kong for three decades. Shirley graduated, cum laude, from Harvard College and has also studied and worked in Tokyo and Madrid. After retiring from Goldman Sachs, she earned her masters and doctorate from the University of Hong Kong and launched a new career as a scholar, policy analyst, and corporate and non-profit director.
Head of Cabinet of the Ministry of University and Research
Marcella Panucci joined Confindustria in 1995, working as Director of Legislative Affairs before being appointed Director General in 2012 until 2020. From 2011 to 2012 she was Head of the Technical Secretariat and Economic Advisor to the Minister of Justice Paola Severino. From 2012 to 2020 she was a member of the Corporate Governance Committee of Borsa Italiana SpA and since 2017 she has been Adjunct Professor of Public Law of Economics at Luiss-Guido Carli University. Since November 2020, she has been a Consultant of Cleary Gottlieb Steen & Hamilton LLP, Legal Advisor to the Minister of European Affairs Vincenzo Amendola and was recently appointed Chief of Staff of the Minister of the Public Administration in the Italian Government. She is the author of several publications in the field of economic law.
Co-Director of the Institute of Global Health Innovation, Imperial College London
Lord Ara Darzi is an academic surgeon who has led numerous innovations in surgical practice and was knighted for his services in medicine and surgery in 2002. In 2007 he was appointed to the UK Department of Health to lead a major review of the NHS. In 2009 Lord Darzi was appointed as the UK’s Global Ambassador for Health and Life Sciences until March 2013. He sat as a Council Member for the UK’s Engineering and Physical Sciences Research Council from 2013-2018 and is Director of the Institute of Global Health Innovation, Imperial College London. He has been a member of Her Majesty’s Most Honourable Privy Council since June 2009 and in 2016, Lord Darzi was awarded the Order of Merit by Her Majesty the Queen for exceptionally meritorious service towards the advancement of medicine.
Director, The Peter Doherty Institute for Infection and Immunity
Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity; Melbourne Laureate Professor, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and Royal Melbourne Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Her research focuses on HIV infection. She has published over 300 publications and in 2019 was named a Clarivate Web of Science high citation researcher. She leads a large national network funded by the National Health and Medical Research Council of Australia which focuses on pandemic preparedness. Scientists from the Doherty Institute were the first to isolate and share the SARS COV2 virus outside of China and have a broad program of research focused on COVID19.
Associate Professor at MIT Media Lab
Ramesh Raskar is Associate Professor at MIT Media Lab, where his research interests span the fields of computational photography, inverse problems in imaging and human-computer interaction. Recent projects include a next generation CAT-Scan machine and low-cost eye care devices. In 2004, Ramesh received the TR100 Award from Technology Review, which recognizes top young innovators and in 2003 the Global Indus Technovator Award, instituted at MIT to recognize the top 20 Indian technology innovators worldwide. Other awards include 2010 LAUNCH Health Innovation Award, presented by NASA, USAID, US State Dept and NIKE, and 2011 Vodafone Wireless Innovation Project Award. Ramesh holds over 40 US patents and has received four Mitsubishi Electric Invention Awards.
Director of the Center for Health Systems and Policy Research, Chinese University of Hong Kong
Eng-Kiong Yeoh is Professor of Public Health, Head of Division of Health System, Policy and Management, and Director of Centre for Health Systems and Policy Research at the JC School of Public Health and Primary Care (School) at The Chinese University of Hong Kong (CUHK). He was Director of the School from 2014 to 2020. His research is in health systems, services, and policy with an interest in applying systems thinking in studying how the complex components of health systems interact and interrelate to improve health. He has a vast experience and knowledge in health systems research and in social and elderly services. Eng-Kiong is currently the principal investigator of two commissioned studies (i) to investigate Hong Kong’s early detection, assessment, and response system to COVID-19 and (ii) to evaluate a new primary care initiative—an innovative district health system in Hong Kong. He is a member of the World Health Organization (WHO) Social Science Research Group on COVID-19 and is leading a study of government responses in the Western Pacific Region. He also completed a study to evaluate the impact of a government elderly healthcare voucher schemes on healthcare utilization and a study to review, develop, and pilot integrated health service models for an aging population. He has been commissioned by the Social Welfare Department to evaluate two pilot projects on (i) Residential Care Service Vouchers for the Elderly and (ii) Support for Elderly Persons Discharged from Public Hospitals after Treatment with an aim to enhance residential care and transitional care services for the elderly. He has just completed a commissioned study by the Macao Health Bureau to assess their population healthcare needs so as to inform the planning of services and resources necessary to meet the changing health needs of Macao population. In addition, the Hong Kong Jockey Club Charities Trust has funded him to conduct research to promote intergenerational cohesion and population health by launching theoretical- and evidence-based intergenerational programs with the collaboration of NGOS in the community. In the aspect of regulation, he is the principal investigator of two projects regarding the regulation of healthcare professions. He has developed and piloted the first accredited registers scheme for unregulated healthcare professionals in Hong Kong. Currently, he is developing criteria for assessing the healthcare professions to recommend appropriate regulatory oversight. These projects can provide insight in developing the regulatory framework for healthcare professionals in Hong Kong to enable better quality of care and improve patient safety in society. He is a member of the Research Council of Our Hong Kong Foundation and led two health policy research projects for the Foundation, namely An Investment for the Celebration of Aging and Fit for Purpose: A Health System for the 21st Century. Internationally, he is involved in collaborative work with research networks such as the Worldwide Universities Network (WUN), the Association of Pacific Rim Universities, and the Asia-Pacific Network for Health Systems Strengthening (ANHSS) in studies on health systems and training for policy. He was Chairman of the ANHSS from July 2009 to June 2014 and serves as Cluster Leader for Knowledge Events. He also supports the work in health system of the Western Pacific Region of the WHO, undertaking commissioned research and acting as Temporary Advisor to provide technical support for strengthening health systems. He has provided consultancy reports on governance and hospital planning. He was President of the International Hospital Federation and has been a member of the International Advisory Board of the National University of Singapore Initiative to improve health in Asia, which seeks to contribute to thinking and policy formulation in public health and health systems development in Asia. Eng-Kiong was Secretary for Health, Welfare and Food of the Government of the Hong Kong Special Administrative Region between 1999 and 2004. From 1990 to 1999, he was head and the first Chief Executive of the Hong Kong Hospital Authority.